New

North America Hypertrophic and Keloid Scar Treatment Market

2021

North America Hypertrophic and Keloid Scar Treatment Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Scar Type (Hypertrophic and Keloid), Product Type (Laser Products, Topical Products, Injectables, Other Products), and End User (Hospitals, Clinics, and Homecare)

Publication Month: Oct 2021 | Report Code: TIPRE00025199 | No. of Pages: 89 | Category: Medical Device | Status: Published

Market Insights

North America Hypertrophic and Keloid Scar Treatment Market to Grow at a CAGR of 10.8% to reach US$ 4,053.90 million from 2020 to 2027

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The hypertrophic and keloid scar treatment market in North America is expected to grow from US$ 1,972.60 million in 2020 to US$ 4,053.90 million by 2027; it is estimated to grow at a CAGR of 10.8% from 2020 to 2027.


The US, Canada, and Mexico are major economies in North America. Advantages of laser treatment is the major factor driving the growth of the North America hypertrophic and keloid scar treatment market. Technological advancements have led to the successful use of laser—especially 585 nm PDL, Q-switched 532 nm frequency-doubled Nd: YAG, and CO2 lasers, among other types—for treating hypertrophic and keloid scars. The laser treatment helps prevent scar formation after surgery; it reduces pain and itching and allows movement that is otherwise limited by the scar. The treatment is widely employed to treat hypertrophic and keloid scars caused by burns. According to the “Laser Management of Hypertrophic Burn Scars: a Comprehensive Review,” published in January 2020, burn-related injury follows more than 70% of hypertrophic scars. Similarly, according to the World Health Organization (WHO), burn is the major public health problem. Every year, ~265,000 deaths are registered due to scalds, electrical burns, and other burn forms. Moreover, 90% of the burn incidences are reported in low- and middle-income countries. As excessive collagen deposition leads to the generation of hypertrophic scars that lead to raised scars, laser treatment proves to be effective against them. Moreover, due to being a minimally invasive method, it ensures reduced scar thickness, pain, and postoperative recovery period. It also helps prevent the need for surgical excision and improves skin pigmentation, pliability, height, pruritus, texture, and heat sensitivity, among other skin conditions of the affected areas. Moreover, this treatment procedure proves to be cost-effective, especially for those opting for medical tourism. Owing to such advantages, there is high demand for the laser treatment curing hypertrophic and keloid scars, which is further anticipated to drive the market in North America.

North America is witnessing a growing number of COVID-19 cases; for instance, the number of cases increased to 400,549 with 12,857 deaths reported in the US. Additionally, Mexico and Canada cases are also growing. The global impacts of COVID-19 have affected several markets, including the hypertrophic and keloid scar treatment market. Although the healthcare sector has witnessed H1N1, SARS, and additional outbreaks in the last few years, the COVID-19 virus has made the situation more difficult due to its transmission mode. Since the outbreak of COVID-19, North America has been witnessing a growing number of COVID-19 cases. Several measures are being taken to restrain the disease and prevent transmission; nevertheless, the excessive number of COVID-19 cases has resulted in the cancellation of doctor's appointment and decreased demand for elective hypertrophic and keloid scar treatment to the long period of lockdown. In the US, due to the growing number of contaminated patients, healthcare practitioners and leading organizations are distracting the flow of health services from research and development to primary care, which slows down the process of innovation.

Get more information on this report :


North America Hypertrophic and Keloid Scar Treatment Market Segmentation

North America Hypertrophic and Keloid Scar Treatment Market – By Scar Type

  • Hypertrophic
  • Keloid

North America Hypertrophic and Keloid Scar Treatment Market – By Product Type

  • Injectables
  • Topical
    • Gels
    • Silicone Sheets
    • Creams
    • Other
  • Laser
    • CO2
    • Pulse-Dyed
    • Other
  • Other

North America Hypertrophic and Keloid Scar Treatment Market – By End User

  • Hospitals
  • Clinics
  • Homecare

North America Hypertrophic and Keloid Scar Treatment Market, by Country

  • US
  • Canada
  • Mexico

North America Hypertrophic and Keloid Scar Treatment Market-Companies Mentioned

  • Alliance Pharma PLC
  • HRA Pharma
  • Mölnlycke Health Care AB.
  • Newmedical Technology Inc.
  • Perrigo Company plc
  • Rejûvaskin
  • Smith & Nephew
  • Sonoma Pharmaceuticals, Inc
  • Suneva Medical

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Hypertrophic and Keloid Scar Treatment Market – By Scar Type

1.3.2 North America Hypertrophic and Keloid Scar Treatment Market – By Product Type

1.3.3 North America Hypertrophic and Keloid Scar Treatment Market – By End User

1.3.4 North America Hypertrophic and Keloid Scar Treatment Market – By Country

2. North America Hypertrophic and Keloid Scar Treatment Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Hypertrophic and Keloid Scar Treatment Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America– PEST Analysis

4.3 Expert Opinion

5. North America Hypertrophic and Keloid Scar Treatment Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Advantages of Laser Treatment

5.1.2 Increasing Cases of Injuries

5.2 Market Restraints

5.2.1 Unavailability of Universal Treatment Due to High Costs, Side Effects, and Scanty Awareness

5.3 Market Opportunities

5.3.1 Tapping Market in Emerging Country

5.4 Future Trends

5.4.1 Emerging Treatments Modalities

5.5 Impact Analysis

6. Hypertrophic and Keloid Scar Treatment Market – North America Analysis

6.1 North America Hypertrophic and Keloid Scar Treatment Market Revenue Forecast and Analysis

7. North America Hypertrophic and Keloid Scar Treatment Market– By Scar Type

7.1 Overview

7.2 North America Hypertrophic and Keloid Scar Treatment Market Share, by Scar Type, 2019 and 2027 (%)

7.3 Hypertrophic

7.3.1 Overview

7.3.2 Hypertrophic: North America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

7.4 Keloid

7.4.1 Overview

7.4.2 Keloid: North America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8. North America Hypertrophic and Keloid Scar Treatment Market– By Product Type

8.1 Overview

8.2 North America Hypertrophic and Keloid Scar Treatment Market Share, by Product Type, 2019 and 2027 (%)

8.3 Laser Products

8.3.1 Overview

8.3.2 Laser Products: North America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.3.2.1 CO2 Market

8.3.2.1.1 Overview

8.3.2.1.2 CO2 Market: North America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.3.2.2 Pulse-Dyed Market

8.3.2.2.1 Overview

8.3.2.2.2 Pulse-Dyed Market: North America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.3.2.3 Other Laser Products Market

8.3.2.3.1 Overview

8.3.2.3.2 Other Laser Products: North America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.4 Topical Products

8.4.1 Overview

8.4.2 Topical Products: North America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.4.2.1 Creams Market

8.4.2.1.1 Overview

8.4.2.1.2 Creams: North America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.4.2.2 Gels Market

8.4.2.2.1 Overview

8.4.2.2.2 Gels: North America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.4.2.3 Silicone Sheets Market

8.4.2.3.1 Overview

8.4.2.3.2 Silicone Sheets: North America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.4.2.4 Other Topical Products Market

8.4.2.4.1 Overview

8.4.2.4.2 Others Topical Products: North America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.5 Injectables

8.5.1 Overview

8.5.2 Injectables: North America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.6 Other Products

8.6.1 Overview

8.6.2 Other Products: North America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

9. North America Hypertrophic and Keloid Scar Treatment Market– By End User

9.1 Overview

9.2 North America Hypertrophic and Keloid Scar Treatment Market Share, by End User, 2019 and 2027 (%)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: North America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

9.4 Clinics

9.4.1 Overview

9.4.2 Clinics: North America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

9.5 Homecare

9.5.1 Overview

9.5.2 Homecare: North America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

10. North America Hypertrophic and Keloid Scar Treatment Market – Country Analysis

10.1 North America: Hypertrophic and Keloid Scar Treatment Market

10.1.1 Overview

10.1.2 North America: Hypertrophic and Keloid Scar Treatment Market, by Country, 2019 & 2027 (%)

10.1.3 US: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.3.1 US: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.3.2 US: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)

10.1.3.3 US: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)

10.1.3.3.1 US: Laser Products Market, by Type, 2018–2027 (USD Million)

10.1.3.3.2 US: Topical Products Market, by Type, 2018–2027 (USD Million)

10.1.3.4 US: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)

10.1.4 Canada: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.4.1 Canada: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.4.2 Canada: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)

10.1.4.3 Canada: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)

10.1.4.3.1 Canada: Laser Products Market, by Type, 2018–2027 (USD Million)

10.1.4.3.2 Canada: Topical Products Market, by Type, 2018–2027 (USD Million)

10.1.4.4 Canada: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)

10.1.5 Mexico: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.5.1 Mexico: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.5.2 Mexico: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)

10.1.5.3 Mexico: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)

10.1.5.3.1 Mexico: Laser Products Market, by Type, 2018–2027 (USD Million)

10.1.5.3.2 Mexico: Topical Products Market, by Type, 2018–2027 (USD Million)

10.1.5.4 Mexico: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)

11. Impact Of COVID-19 Pandemic on North America Hypertrophic and Keloid Scar Treatment Market

11.1 North America: Impact Assessment of COVID-19 Pandemic

12. North America Hypertrophic and Keloid Scar Treatment Market–Industry Landscape

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. COMPANY PROFILES

13.1 Alliance Pharma PLC

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Mölnlycke Health Care AB.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Smith & Nephew

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Newmedical Technology Inc.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Rejûvaskin

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Sonoma Pharmaceuticals, Inc.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Suneva Medical

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 HRA Pharma

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Perrigo Company plc

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. North America Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (US$ Million)

Table 2. US: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)

Table 3. US: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 4. US: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 5. US: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 6. US: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 7. Canada: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)

Table 8. Canada: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 9. Canada: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 10. Canada: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 11. Canada: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 12. Mexico: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)

Table 13. Mexico: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 14. Mexico: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 15. Mexico: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 16. Mexico: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 17. Organic Developments Done By Companies

Table 18. Inorganic Developments Done By Companies

Table 19. Glossary of Terms, North America Hypertrophic and Keloid Scar Treatment Market

LIST OF FIGURES

Figure 1. North America Hypertrophic and Keloid Scar Treatment Market Segmentation

Figure 2. North America Hypertrophic and Keloid Scar Treatment Market, By Country

Figure 3. North America Hypertrophic and Keloid Scar Treatment Market Overview

Figure 4. Hypertrophic Segment Held Largest Share of Scar Type Segment in North America Hypertrophic and Keloid Scar Treatment Market

Figure 5. US Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. North America PEST Analysis

Figure 7. Expert Opinion

Figure 8. North America Hypertrophic and Keloid Scar Treatment Market Impact Analysis of Drivers and Restraint

Figure 9. North America Hypertrophic and Keloid Scar Treatment Market – Revenue Forecast and Analysis – 2018- 2027

Figure 10. North America Hypertrophic and Keloid Scar Treatment Market Share, by Scar Type, 2019 and 2027 (%)

Figure 11. Hypertrophic: North America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 12. Keloid: North America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 13. North America Hypertrophic and Keloid Scar Treatment Market Share, by Product Type, 2019 and 2027 (%)

Figure 14. Laser Products: North America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 15. CO2 Market: North America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 16. Pulse-Dyed Market: North America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 17. Other Laser Products Market: North America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 18. Topical Products: North America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 19. Creams: North America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 20. Gels: North America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 21. Silicone Sheets Market: North America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 22. Other Topical Products Market: North America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 23. Injectables: North America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 24. Other Products: North America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 25. North America Hypertrophic and Keloid Scar Treatment Market Share, by End User, 2019 and 2027 (%)

Figure 26. Hospitals: North America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 27. Clinics: North America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 28. Homecare: North America Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 29. North America: Hypertrophic and Keloid Scar Treatment Market, by Key Country – Revenue (2019) (USD Million)

Figure 30. North America: Hypertrophic and Keloid Scar Treatment Market, by Country, 2019 & 2027 (%)

Figure 31. US: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

Figure 32. Canada: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

Figure 33. Mexico: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

Figure 34. Impact of COVID-19 Pandemic In North American Country Markets

  1. Alliance Pharma PLC
  2. HRA Pharma
  3. Mölnlycke Health Care AB.
  4. Newmedical Technology Inc.
  5. Perrigo Company plc
  6. Rejûvaskin
  7. Smith & Nephew
  8. Sonoma Pharmaceuticals, Inc
  9. Suneva Medical
  • To understand the North America hypertrophic and keloid scar treatment market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for North America hypertrophic and keloid scar treatment market
  • Efficiently plan M&A and partnership deals in North America hypertrophic and keloid scar treatment market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form North America hypertrophic and keloid scar treatment market
  • Obtain market revenue forecast for market by various segments from 2020-2027 in North America region.
TIPRE00025199
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.